Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate
- PMID: 12147798
- DOI: 10.1093/ndt/17.8.1480
Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate
Abstract
Background: It has been speculated that increased levels of circulating or intraperitoneal pro-inflammatory cytokines such as interleukin 6, and pro-angiogenic vascular endothelial growth factor (VEGF) may contribute to high peritoneal small-solute transport rate (PSTR) in continuous ambulatory peritoneal dialysis (CAPD) patients. In this study we evaluated possible relationships between plasma and dialysate IL-6 and VEGF levels and PSTR.
Methods: Forty CAPD patients (mean age+/-SD of 58+/-14 years) with no apparent inflammation process or disease, who had been on CAPD for 19+/-15 months (range 3-56 months) were included in the study. Peritoneal equilibration test (PET) was used to evaluate PSTR. Patients were divided into two groups: high-average and high transporters (H/A; D/P(creat)>/=0.65) and low-average and low transporters (L/A; D/P(creat)<0.64). Albumin and IgG clearances were used in the evaluation of permeability to larger solutes. Plasma and overnight dialysate levels of IL-6 and VEGF were measured.
Results: Plasma IL-6 (7.6 vs 4.3 pg/ml) and VEGF (342 vs 163 pg/ml) as well as dialysate IL-6 (174 vs 80 pg/ml) and VEGF (96 vs 69 pg/ml) levels were significantly higher in the H/A than in the L/A group. The dialysate appearance of IL-6 and VEGF correlated with D/P(creat), as well as with albumin and IgG clearances. Moreover, significant correlations were noted between dialysate IL-6 and dialysate VEGF levels.
Conclusions: The findings of (i) increased plasma and dialysate levels of IL-6 and VEGF in the H/A group compared to the L/A group, (ii) an association between PSTR and both plasma and dialysate IL-6 and VEGF levels, and (iii) a significant correlation between dialysate IL-6 and VEGF concentrations suggest that inflammation, angiogenesis, and peritoneal transport may be interrelated and involved in the pathophysiology of high PSTR in CAPD patients. However, due to the cross-sectional design of this study, the cause and effect relationships between plasma and dialysate IL-6 and VEGF concentrations and high PSRT remain unclear.
Similar articles
-
Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.Perit Dial Int. 2002 Nov-Dec;22(6):670-6. Perit Dial Int. 2002. PMID: 12556068 Clinical Trial.
-
Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.Perit Dial Int. 2006 Jan-Feb;26(1):53-63. Perit Dial Int. 2006. PMID: 16538876
-
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.Nephrol Dial Transplant. 2010 May;25(5):1639-46. doi: 10.1093/ndt/gfp670. Epub 2010 Jan 8. Nephrol Dial Transplant. 2010. PMID: 20061317
-
Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?Perit Dial Int. 2006 May-Jun;26(3):341-8. Perit Dial Int. 2006. PMID: 16722027 Clinical Trial.
-
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review.
Cited by
-
High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: A prospective cohort study.Front Med (Lausanne). 2022 Aug 10;9:836861. doi: 10.3389/fmed.2022.836861. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035388 Free PMC article.
-
An update on peritoneal dialysis solutions.Nat Rev Nephrol. 2012 Feb 21;8(4):224-33. doi: 10.1038/nrneph.2012.13. Nat Rev Nephrol. 2012. PMID: 22349485 Review.
-
Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.Perit Dial Int. 2013 May-Jun;33(3):242-51. doi: 10.3747/pdi.2011.00270. Epub 2012 Nov 1. Perit Dial Int. 2013. PMID: 23123670 Free PMC article.
-
Peritoneal changes in patients on long-term peritoneal dialysis.Nat Rev Nephrol. 2013 Jul;9(7):419-29. doi: 10.1038/nrneph.2013.99. Epub 2013 May 14. Nat Rev Nephrol. 2013. PMID: 23670085 Review.
-
Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function.NDT Plus. 2009 Apr;2(2):104-110. doi: 10.1093/ndtplus/sfn203. Epub 2009 Jan 15. NDT Plus. 2009. PMID: 19461865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical